Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

LA GRANDE PHARMACIE DU CARRE D'AS : revenue, balance sheet and financial ratios

LA GRANDE PHARMACIE DU CARRE D'AS is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BELLERIVE-SUR-ALLIER (03700), this company of category PME shows in 2024 a net income positive of 246 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LA GRANDE PHARMACIE DU CARRE D'AS (SIREN 832119408)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 246 219 € 180 255 € 188 806 € 296 799 € 239 709 € 268 153 € 5 701 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, LA GRANDE PHARMACIE DU CARRE D'AS generates positive net income of 246 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 6 k€ -> 246 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

246 219 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 140%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

139.533%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.319%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

60.6%

Solvency indicators evolution
LA GRANDE PHARMACIE DU CARRE D'AS

Sector positioning

Debt ratio
139.53 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of LA GRANDE PHARMACIE DU CA... (139.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.32% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +8 pts over 3 years

In 2024, the financial autonomy of LA GRANDE PHARMACIE DU CA... (35.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 116.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

116.618

Liquidity indicators evolution
LA GRANDE PHARMACIE DU CARRE D'AS

Sector positioning

Liquidity ratio
116.62 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch

In 2024, the liquidity ratio of LA GRANDE PHARMACIE DU CA... (116.62) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of LA GRANDE PHARMACIE DU CARRE D'AS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of LA GRANDE PHARMACIE DU CARRE D'AS is estimated at 3 437 399 € (range 2 393 750€ - 5 142 545€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2393k€ 3437k€ 5142k€
3 437 399 € Range: 2 393 750€ - 5 142 545€
NAF 5 année 2024

Valuation method used

Net Income Multiple
246 219 € × 14.0x = 3 437 399 €
Range: 2 393 750€ - 5 142 546€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare LA GRANDE PHARMACIE DU CARRE D'AS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about LA GRANDE PHARMACIE DU CARRE D'AS

What is the revenue of LA GRANDE PHARMACIE DU CARRE D'AS ?

The revenue of LA GRANDE PHARMACIE DU CARRE D'AS is not publicly disclosed (confidential accounts filed with INPI).

Is LA GRANDE PHARMACIE DU CARRE D'AS profitable?

Yes, LA GRANDE PHARMACIE DU CARRE D'AS generated a net profit of 246 k€ in 2024.

Where is the headquarters of LA GRANDE PHARMACIE DU CARRE D'AS ?

The headquarters of LA GRANDE PHARMACIE DU CARRE D'AS is located in BELLERIVE-SUR-ALLIER (03700), in the department Allier.

Where to find the tax return of LA GRANDE PHARMACIE DU CARRE D'AS ?

The tax return of LA GRANDE PHARMACIE DU CARRE D'AS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LA GRANDE PHARMACIE DU CARRE D'AS operate?

LA GRANDE PHARMACIE DU CARRE D'AS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.